Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited operates as a subsidiary of Ipca Laboratories Ltd.
Metrics to compare | UNLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipUNLBPeersSector | |
---|---|---|---|---|
P/E Ratio | 31.2x | 13.0x | −0.5x | |
PEG Ratio | 0.13 | 0.11 | 0.00 | |
Price/Book | 1.7x | 1.3x | 2.6x | |
Price / LTM Sales | 2.0x | 1.3x | 3.3x | |
Upside (Analyst Target) | - | 16.5% | 45.1% | |
Fair Value Upside | Unlock | 6.9% | 7.4% | Unlock |